BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8548874)

  • 21. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
    Abulrob AN; Mason M; Bryce R; Gumbleton M
    J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of idarubicin and daunorubicin and their main metabolites regarding intracellular uptake and effect on sensitive and multidrug-resistant HL60 cells.
    Tidefelt U; Prenkert M; Paul C
    Cancer Chemother Pharmacol; 1996; 38(5):476-80. PubMed ID: 8765443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines.
    Meesungnoen J; Jay-Gerin JP; Mankhetkorn S
    Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake of pirarubicin, daunorubicin and doxorubicin.
    Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
    Biol Pharm Bull; 1994 Sep; 17(9):1305-8. PubMed ID: 7841960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of adriamycin cytotoxicity and transport in drug-sensitive and multidrug-resistant Chinese hamster ovary cells by hyperthermia and cyclosporin A.
    Larrivée B; Averill DA
    Cancer Chemother Pharmacol; 2000; 45(3):219-30. PubMed ID: 10663640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
    Kim SS; Seong S; Lim SH; Kim SY
    Anticancer Res; 2013 Nov; 33(11):4913-9. PubMed ID: 24222129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line.
    Li XF; Kinuya S; Yokoyama K; Konishi S; Ma YY; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Cancer Biother Radiopharm; 2001 Feb; 16(1):17-23. PubMed ID: 11279794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF.
    Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ
    Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport mechanism of anthracycline derivatives in rat polymorphonuclear leukocytes: uptake and efflux of pirarubicin.
    Nagasawa K; Nomiyama M; Ohnishi N; Yokoyama T; Iwakawa S; Okumura K
    Biol Pharm Bull; 1994 May; 17(5):696-700. PubMed ID: 7920436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difloxacin reverses multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related protein (MRP) gene.
    Gollapudi S; Thadepalli F; Kim CH; Gupta S
    Oncol Res; 1995; 7(5):213-25. PubMed ID: 8534927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
    Evans CH; Baker PD
    Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
    Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T
    Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance.
    Andrivon W; Monneret C; Nafziger J; Florent JC; Guillosson JJ
    Leuk Res; 1998 Aug; 22(8):719-25. PubMed ID: 9680099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthraquinone antitumour agents, doxorubicin, pirarubicin and benzoperimidine BP1, trigger caspase-3/caspase-8-dependent apoptosis of leukaemia sensitive HL60 and resistant HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    Anticancer Drugs; 2012 Apr; 23(4):380-92. PubMed ID: 22198116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance.
    Baran Y; Gür B; Kaya P; Ural AU; Avcu F; Gündüz U
    Hematology; 2007 Dec; 12(6):511-7. PubMed ID: 17852453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.